2108 logo

The Global Hydroxychloroquine market is forecasted to reach USD 5.54 Billion by 2027, according to a new report by Reports and Data. The medication is widely used in the treatment of acute attacks of malaria, and rheumatoid arthritis, among other conditions. The fact that the medicine is a chemotherapeutic agent, which acts against erythrocytic forms of malarial parasites, is one of the major reasons for its extensive use in malaria treatment, which is in high demand in third world countries due to high incidence rate of malaria. However, with COVID-19 pandemic, the scenario in terms of demand for the medication has changed drastically, which sudden interest of nations like the U.S. on getting the medication. This sudden elevation in demand of the mediation is attributed to its demonstrated antiviral activity against (SARS–CoV-2), severe acute respiratory syndrome–coronavirus 2 in certain clinical studies.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2933

Top Companies operating in the Market and Profiled in the Report include:

Hikma Pharmaceuticals PLC, Cadila Healthcare Ltd, Ipca Laboratories Ltd, Novartis AG, Mylan N.V, Sanofi S.A., Taj Pharmaceuticals Ltd., Shanghai Pharmaceuticals Holding Co., Ltd, Torrent Pharmaceuticals Ltd, Teva Pharmaceutical Industries Ltd., and Zydus Cadila.

Further key findings from the report suggest

  • In context to Product Type, the Injection segment is projected to witness a considerable growth rate of 31.2% during the forecast period. The growth of the Injection segment is attributed to its quick action and high demand in a large number of trials.
  • In regards to Distribution Channel, the Hospital pharmacy is projected to hold more than 35.0% of the market in 2019. The fact that a large number of patients with malaria and COVID-19 are admitted to hospitals for treatment results in high preference and dependence on this distribution channel for availing the medicine, contributing to the market share held by this segment.
  • In context to Application, the COVID-19 segment is projected to witness the fastest growth rate of 36.0% during the forecast period. As this is a new condition and a large number of trials are conducted on the effectiveness of the medicine in treating the condition, it would contribute to the growth rate witnessed by this segment.
  • In April 2019, Ipca Laboratories had signed a contract to acquire Maharashtra-based Ramdev Chemical. According to the contract, Ipca Laboratories is supposed to buy the company for Rs 108.5 crore. Ramdev Chemical is associated with the marketing and manufacturing of active pharmaceutical ingredients (APIs), advanced drug intermediates, custom synthesis molecules, and fine chemicals. Thus, this initiative by Ipca Laboratories would not only help the company in increasing the production capacity of the drug.

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/2933

The report discusses in detail the top companies in the market along with their recent initiatives such as mergers and acquisitions, joint venture, partnerships, corporate and government deals, collaborations, and brand promotions and product launches among others. The report further discusses the companies’ initiatives and investments in key regions across the globe such as North America, Europe, Latin America, Asia Pacific, and Middle East & Africa.

Region analysis Covers:

  • North America (U.S.A., Canada, Mexico)
  • Europe (U.K., Italy, Germany, France, Rest of Europe)
  • Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
  • Latin America (Chile, Brazil, Argentina, Rest of Latin America)
  • Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Product Type Outlook (Volume, Kilo Tons; Revenue, USD Million; 2017-2027)

  • Tablets
  • Injection

Distribution channel Outlook (Volume, Kilo Tons; Revenue, USD Million; 2017-2027)

  • Hospital pharmacy
  • Online pharmacy
  • Speciality drug stores
  • Retail pharmacy

Application Outlook (Volume, Kilo Tons; Revenue, USD Million; 2017-2027)

  • Malaria
  • Rheumatoid arthritis
  • Lupus Erythematosus
  • COVID-19
  • Others

Read More Reports

Medical/Diagnostic Imaging Market @ https://www.biospace.com/article/medical-diagnostic-imaging-market-to-reach-usd-37-02-billion-by-2027-reports-and-data/

Urological Devices Market @ https://www.biospace.com/article/urological-devices-market-to-reach-usd-62-76-billion-by-2027-reports-and-data/

Tomosynthesis Market @ https://www.biospace.com/article/tomosynthesis-market-to-reach-usd-3-70-billion-by-2026-reports-and-data/

Stereotactic Surgery Devices Market @ https://www.biospace.com/article/stereotactic-surgery-devices-market-to-reach-usd-24-73-billion-by-2027-reports-and-data/

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

To know more about the report @  https://www.reportsanddata.com/press-release/global-hydroxychloroquine-market

Tags: Hydroxychloroquine Market Growth, Hydroxychloroquine size, Hydroxychloroquine market demand, Hydroxychloroquine trend

See Campaign: https://www.reportsanddata.com/press-release/global-hydroxychloroquine-market

Contact Information:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: [email protected]


Reportedtimes, PR-Wirein, iCN Internal Distribution, Research Newswire, English